HSPB2 and gastric cancer: Moreover, we detected the upregulation of ACSM5 and HSPB2 in H. pylori+ GC patients, underscoring the need for tailored therapeutic strategies for H. pylori-infected GC patients based on ACSM5 and HSPB2 expression levels.